Inhibition of Prostaglandin Synthesis as a Mechanism of Action for Aspirin-like Drugs
The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“CBT for insomnia (CBT-I) is considered the first-line treatment for insomnia (557) and outperforms pharmacological interventions, in particular with respect to maintenance of therapeutic effects at long-term follow-up (270, 513).”
From The Sleep-Immune Crosstalk in Health and Disease (2019) · cites this paper as [557]
Citations
Cites
Aspirin Selectively Inhibits Prostaglandin Production in Human Platelets
SMITH, J. B., & WILLIS, A. L. (1971) · Nature New Biology · doi:10.1038/newbio231235a0 · Cited by 1,521
Indomethacin and Aspirin abolish Prostaglandin Release from the Spleen
FERREIRA, S. H., MONCADA, S., & VANE, J. R. (1971) · Nature New Biology · doi:10.1038/newbio231237a0 · Cited by 941
Self-citationProstaglandins: Their Disappearance from and Release into the Circulation
FERREIRA, S. H., & VANE, J. R. (1967) · Nature · doi:10.1038/216868a0 · Cited by 892
Self-citationRelease of Additional Factors in Anaphylaxis and its Antagonism by Anti-inflammatory Drugs
PIPER, P. J., & VANE, J. R. (1969) · Nature · doi:10.1038/223029a0 · Cited by 880
Self-citationA SENSITIVE METHOD FOR THE ASSAY OF 5‐HYDROXYTRYPTAMINE
VANE, J. R. (1957) · British Journal of Pharmacology and Chemotherapy · doi:10.1111/j.1476-5381.1957.tb00146.x · Cited by 772
Self-citationTHE PROSTAGLANDINS: A FAMILY OF BIOLOGICALLY ACTIVE LIPIDS
BERGSTRÖM, S., CARLSON, L. A., & WEEKS, J. R. (1968) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)07108-x · Cited by 634
Prostaglandins released by the Spleen
Gilmore, N. J., Vane, J. R., & Wyllie, J. H. (1968) · Nature · doi:10.1038/2181135a0 · Cited by 548
Self-citationProstaglandins and related factors: XIX. Thin-layer chromatography of prostaglandins
Gréen, K., & Samuelsson, B. (1964) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)40270-6 · Cited by 476
Cutaneous reactions to intradermal prostaglandins
Crunkhorn, P., & Willis, A. L. (1971) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1971.tb09934.x · Cited by 348
The enzymic conversion of all‐cis 8,11,14‐eicosatrienoic acid into prostaglandin E1
Nugteren, D. H., Beerthuis, R. K., & van Dorp, D. A. (1966) · Recueil des Travaux Chimiques des Pays-Bas · doi:10.1002/recl.19660850412 · Cited by 339
Research works printed but not linked: 11
- Jacques, R., Helv. Physiol. Pharmacol. Acta, 23, 156 (1965).
- Berry, P. A., thesis, Council for National Academic Awards, London, 91 (1966).
- Vargaftig, B. B., and Dao, N., Pharmacology (in the press).
- Piper, P. J., and Vane, J. R., in Prostaglandins (edit. by Ramwell, P., and Shaw, J.) (NY Acad. Sci., in the press, 1971).
- Willis, A. L., Brit. J. Pharmacol., 40, 583P (1970).
- Milton, A. S., and Wendlandt, S. J., J. Physiol., 207, 76P (1970).
- Feldberg, W., and Saxena, P. N., J. Physiol. (in the press, 1971).
- Willis, A. L., in Prostaglandins, Peptides and Amines (edit. by Mantegazza, P., and Horton, E. W.), 31 (Academic Press, London, 1969).
- Collier, H. O. J., Nature (in the press).
- Goodman, L. S., and Gilman, A., The Pharmacological Basis ofTherapeutics, fourth ed. (Collier-Macmillan, London, 1970).
- Hucker, H. B., Zacchei, A. G., Cox, S. V., Brodie, D. A., and Cantwell, N. H. R., J. Pharmac. Exp. Therap., 153, 237 (1966).
Cited by
Items 301–400 of 1,039
Paulson, S. K., Vaughn, M. B., Jessen, S. M., Lawal, Y., Gresk, C. J., Yan, B., Maziasz, T. J., Cook, C. S., & Karim, A. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29580-x · Cited by 289
Flower, R. J., Cheung, H. S., & Cushman, D. W. (1973) · Prostaglandins · doi:10.1016/0090-6980(73)90020-8 · Cited by 288
Schmassmann, A., Peskar, B. M., Stettler, C., Netzer, P., Stroff, T., Flogerzi, B., & Halter, F. (1998) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701672 · Cited by 287
Celecoxib: A Review of its Use in Osteoarthritis, Rheumatoid Arthritis and Acute Pain
Clemett, D., & Goa, K. L. (2000) · Drugs · doi:10.2165/00003495-200059040-00017 · Cited by 287
Kinetic basis for selective inhibition of cyclo-oxygenases
Gierse, J. K., Koboldt, C. M., Walker, M. C., Seibert, K., & Isakson, P. C. (1999) · Biochemical Journal · doi:10.1042/0264-6021:3390607 · Cited by 287
Paramashivappa, R., Phani Kumar, P., Subba Rao, P. V., & Srinivasa Rao, A. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(02)01006-5 · Cited by 287
Rodemann, H. P., & Goldberg, A. L. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)68084-1 · Cited by 287
HALTER, F., TARNAWSKI, A. S., SCHMASSMANN, A., & PESKAR, B. M. (2001) · Gut · doi:10.1136/gut.49.3.443 · Cited by 285
Fiorucci, S., Meli, R., Bucci, M., & Cirino, G. (2001) · Biochemical Pharmacology · doi:10.1016/s0006-2952(01)00747-x · Cited by 285
Pharmacology of oral combination analgesics: rational therapy for pain
Raffa, R. B. (2001) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1046/j.1365-2710.2001.00355.x · Cited by 284
Lerea, L. S., & McNamara, J. O. (1993) · Neuron · doi:10.1016/0896-6273(93)90239-n · Cited by 284
Verma, A. K., Ashendel, C. L., & Boutwell, R. K. (1980) · PubMed · Cited by 284
Aspirin, salicylates, and cancer
Elwood, P. C., Gallagher, A. M., Duthie, G. G., Mur, L. A., & Morgan, G. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60243-9 · Cited by 282
Evidence for a Role for Prostaglandins in the Initiation of Blastocyst Implantation in the Rat1
Kennedy, T. G. (1977) · Biology of Reproduction · doi:10.1095/biolreprod16.3.286 · Cited by 282
Size- and invasion-dependent increase in cyclooxygenase 2 levels in human colorectal carcinomas.
Fujita, T., Matsui, M., Takaku, K., Uetake, H., Ichikawa, W., Taketo, M. M., & Sugihara, K. (1998) · PubMed · doi:10.11501/3167979 · Cited by 282
AMP-activated protein kinase: maintaining energy homeostasis at the cellular and whole-body levels
Hardie, D. G. (2014) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071812-161148 · Cited by 281
Stimulation and Blockade of Prostaglandin Biosynthesis
Smith, W. L., & Lands, W. E. M. (1971) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)34171-7 · Cited by 281
Ylikorkala, O., & Dawood, M. Y. (1978) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(78)90019-4 · Cited by 280
Mitchell, J. A., & Warner, T. D. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1929 · Cited by 279
Angiotensin II Stimulation of Prostaglandin Production in Cultured Human Vascular Endothelium
Gimbrone, M. A., & Alexander, R. W. (1975) · Science · doi:10.1126/science.1138377 · Cited by 278
Evidence for an in vivo antagonism between vasopressin and prostaglandin in the mammalian kidney.
Anderson, R. J., Berl, T., McDonald, K. D., & Schrier, R. W. (1975) · Journal of Clinical Investigation · doi:10.1172/jci108108 · Cited by 277
Rishton, G. M. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.02.007 · Cited by 276
Host response modulation in the management of periodontal diseases
Salvi, G. E., & Lang, N. P. (2005) · Journal of Clinical Periodontology · doi:10.1111/j.1600-051x.2005.00785.x · Cited by 276
Inhibition of prostaglandin synthesis in man
Hámberg, M. (1972) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(72)90470-6 · Cited by 276
Hussain, A., AlAjmi, M. F., Rehman, M. T., Amir, S., Husain, F. M., Alsalme, A., Siddiqui, M. A., AlKhedhairy, A. A., & Khan, R. A. (2019) · Scientific Reports · doi:10.1038/s41598-019-41063-x · Cited by 275
Animal models and therapeutic molecular targets of cancer: utility and limitations
Cekanova, M., & Rathore, K. (2014) · Drug Design, Development and Therapy · doi:10.2147/dddt.s49584 · Cited by 274
“NSAIDs are among the most widely used prescription and nonprescription drugs in the world.(128,129) Identification of the second isoform of the COX enzyme, COX-2, led to discovery of a new class of COX-2 selective inhibitors, ie, the COXIBs, including rofecoxib, celecoxib, valdecoxib, etoricoxib, and lumiracoxib.”
Prostaglandin Synthetase Inhibitors I
Shen, T. Y. (1979) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-642-66891-3_12 · Cited by 274
MONCADA, S. (1982) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1982.tb09186.x · Cited by 272
Blackwell, G. J., Duncombe, W. G., Flower, R. J., Parsons, M. F., & Vane, J. R. (1977) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1977.tb07500.x · Cited by 272
Self-citationLewis, R., & Schulman, J. (1973) · The Lancet · doi:10.1016/s0140-6736(73)92934-6 · Cited by 271
Lindner, H. R., TSAFRIRI, A., Zor, U., Koch, Y., BAUMINGER, S., Barnea, A., & Lieberman, M. E. (1974) · Elsevier eBooks · doi:10.1016/b978-0-12-571130-2.50007-9 · Cited by 271
Postoperative Analgesic Effects of Celecoxib or Rofecoxib After Spinal Fusion Surgery
Reuben, S. S., & Connelly, N. R. (2000) · Anesthesia & Analgesia · doi:10.1097/00000539-200011000-00032 · Cited by 270
RetractedYaksh, T. L., Dirig, D. M., Conway, C. M., Svensson, C., Luo, Z. D., & Isakson, P. C. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-16-05847.2001 · Cited by 270
COVID-19 outbreak: history, mechanism, transmission, structural studies and therapeutics
Yesudhas, D., Srivastava, A., & Gromiha, M. M. (2021) · Infection · doi:10.1007/s15010-020-01516-2 · Cited by 270
NIH Consensus Statement on Total Knee Replacement December 8-10, 2003*
(2004) · The Journal of Bone and Joint Surgery-American Volume · doi:10.2106/00004623-200406000-00030 · Cited by 269
Renal effects of drugs that inhibit prostaglandin synthesis
Dunn, M. J., & Zambraski, E. J. (1980) · Kidney International · doi:10.1038/ki.1980.179 · Cited by 269
WHITTLE, B. J. R. (1977) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1977.tb07522.x · Cited by 268
Dempsey, D. A., & Klessig, D. F. (2017) · BMC Biology · doi:10.1186/s12915-017-0364-8 · Cited by 266
Mechanism of Free Radical Oxygenation of Polyunsaturated Fatty Acids by Cyclooxygenases
Rouzer, C. A., & Marnett, L. J. (2003) · Chemical Reviews · doi:10.1021/cr000068x · Cited by 266
Day, R. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.12.1781 · Cited by 264
The Neurobiology of Virtual Reality Pain Attenuation
Gold, J. I., Belmont, K. A., & Thomas, D. A. (2007) · CyberPsychology & Behavior · doi:10.1089/cpb.2007.9993 · Cited by 263
The Role of Aspirin in Cardiovascular Prevention
Gasparyan, A. Y., Watson, T., & Lip, G. Y. H. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.11.080 · Cited by 263
Non-steroidal anti-inflammatory drugs and spinal nociceptive processing
McCormack, K. (1994) · Pain · doi:10.1016/0304-3959(94)90045-0 · Cited by 263
Duval, D., Durant, S., & Homo-Delarche, F. (1983) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/0304-4157(83)90008-4 · Cited by 262
Clinical application of prostaglandin E1 (PGE1) upon orthodontic tooth movement
Yamasaki, K., Shibata, Y., Imai, S., Tani, Y., Shibasaki, Y., & Fukuhara, T. (1984) · American Journal of Orthodontics · doi:10.1016/0002-9416(84)90091-5 · Cited by 262
Corticosteroids inhibit prostaglandin production by rheumatoid synovia
Kantrowitz, F. G., Robinson, D. R., McGuire, M. B., & Levine, L. (1975) · Nature · doi:10.1038/258737a0 · Cited by 262
The Anti-Inflammatory Effects of Prostaglandins
Scher, J. U., & Pillinger, M. H. (2009) · Journal of Investigative Medicine · doi:10.2310/jim.0b013e31819aaa76 · Cited by 259
Burian, M., & Geisslinger, G. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.02.004 · Cited by 259
Punchard, N. A., Whelan, C. J., & Adcock, I. M. (2004) · Journal of Inflammation · doi:10.1186/1476-9255-1-1 · Cited by 259
Aspirin-Exacerbated Respiratory Disease
White, A. A., & Stevenson, D. D. (2018) · New England Journal of Medicine · doi:10.1056/nejmra1712125 · Cited by 258
Aspirin-like Molecules that Covalently Inactivate Cyclooxygenase-2
Kalgutkar, A. S., Crews, B. C., Rowlinson, S. W., Garner, C., Seibert, K., & Marnett, L. J. (1998) · Science · doi:10.1126/science.280.5367.1268 · Cited by 258
Eleutherococcus senticosus (Rupr. & Maxim.) Maxim. (Araliaceae) as an adaptogen: a closer look
Davydov, M., & Krikorian, A. D. (2000) · Journal of Ethnopharmacology · doi:10.1016/s0378-8741(00)00181-1 · Cited by 256
Nonsteroidal anti-inflammatory drugs, apoptosis, and colon-cancer chemoprevention
Chan, T. A. (2002) · The Lancet Oncology · doi:10.1016/s1470-2045(02)00680-0 · Cited by 255
The Prodrug Platin‐A: Simultaneous Release of Cisplatin and Aspirin
Pathak, R. K., Marrache, S., Choi, J. H., Berding, T. B., & Dhar, S. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201308899 · Cited by 255
Marom, Z. M., Shelhamer, J. H., & Kaliner, M. (1981) · Journal of Clinical Investigation · doi:10.1172/jci110207 · Cited by 255
Triebskorn, R., Casper, H., Scheil, V., & Schwaiger, J. (2007) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-006-1033-x · Cited by 254
Inhibitors of cyclooxygenases: mechanisms, selectivity and uses.
Botting, R. M. (2006) · PubMed · Cited by 259
Prostaglandin and non-prostaglandin mediated breakdown of the blood-aqueous barrier
Eakins, K. E. (1977) · Experimental Eye Research · doi:10.1016/s0014-4835(77)80043-2 · Cited by 253
Pharmacology of kinins: Their relevance to tissue injury and inflammation
Marceau, F., Lussier, A., Regoli, D., & Giroud, J. P. (1983) · General Pharmacology: The Vascular System · doi:10.1016/0306-3623(83)90001-0 · Cited by 252
Activation of endothelial L-arginine pathway in resistance arteries. Effect of age and hypertension.
Dohi, Y., Thiel, M. A., Bühler, F. R., & Lüscher, T. F. (1990) · Hypertension · doi:10.1161/01.hyp.16.2.170 · Cited by 252
Yasojima, K., Schwab, C., McGeer, E. G., & McGeer, P. L. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01389-x · Cited by 251
Perspectives in Nonsteroidal Anti‐inflammatory Agents
Shen, T. Y. (1972) · Angewandte Chemie International Edition in English · doi:10.1002/anie.197204601 · Cited by 251
Protein‐Reactive Natural Products
Drahl, C., Cravatt, B. F., & Sorensen, E. J. (2005) · Angewandte Chemie International Edition · doi:10.1002/anie.200500900 · Cited by 250
The causes and effects of socio-demographic exclusions from clinical trials
Bartlett, C., Doyal, L., Ebrahim, S., Davey, P., Bachmann, M., Egger, M., & Dieppe, P. (2005) · Health Technology Assessment · doi:10.3310/hta9380 · Cited by 250
Cherny, N. I., & Portenoy, R. K. (1994) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.44.5.263 · Cited by 250
Ventromedial Preoptic Prostaglandin E2 Activates Fever-Producing Autonomic Pathways
Scammell, T. E., Elmquist, J. K., Griffin, J. D., & Saper, C. B. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-19-06246.1996 · Cited by 250
Emim, J. A. D. S., Oliveira, A. B., & Lapa, A. J. (1994) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1994.tb03753.x · Cited by 249
Molecular basis of fever in humans
A. Dinarello, C., & M. Wolff, S. (1982) · The American Journal of Medicine · doi:10.1016/0002-9343(82)90548-4 · Cited by 249
Physiological Regulation of Prostaglandins in the Kidney
Hao, C.-M., & Breyer, M. D. (2008) · Annual Review of Physiology · doi:10.1146/annurev.physiol.70.113006.100614 · Cited by 247
Kato, T., Iwama, Y., Okumura, K., Hashimoto, H., Ito, T., & Satake, T. (1990) · Hypertension · doi:10.1161/01.hyp.15.5.475 · Cited by 247
Present concepts on the mechanisms of platelet aggregation
Vargaftig, B. B., Chignard, M., & Benveniste, J. (1981) · Biochemical Pharmacology · doi:10.1016/0006-2952(81)90052-6 · Cited by 247
Cyclooxygenase expression in microglia and neurons in Alzheimer's disease and control brain
Hoozemans, J. J. M., Rozemuller, A. J. M., Janssen, I., De Groot, C. J. A., Veerhuis, R., & Eikelenboom, P. (2001) · Acta Neuropathologica · doi:10.1007/s004010000251 · Cited by 246
The American academy of orthopaedic surgeons
Rockwood, C. A. (1988) · Current Orthopaedics · doi:10.1016/0268-0890(88)90040-0 · Cited by 245
Auditory sensori-neural alterations induced by salicylate
Cazals, Y. (2000) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00027-7 · Cited by 244
Lewis, G. P., & Piper, P. J. (1975) · Nature · doi:10.1038/254308a0 · Cited by 245
A classification of NSAIDs according to the relative inhibition of cyclooxygenase isoenzymes
Frölich, J. C. (1997) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(96)01017-6 · Cited by 243
Higgs, G. A., Eakins, K. E., Mugridge, K. G., Moncada, S., & Vane, J. R. (1980) · European Journal of Pharmacology · doi:10.1016/0014-2999(80)90297-6 · Cited by 243
Self-citationOxidative stress in inflammation‐based gastrointestinal tract diseases: Challenges and opportunities
Kim, Y. J., Kim, E., & Hahm, K. B. (2012) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2012.07108.x · Cited by 242
Gryglewski, R. J., Panczenko, B., Korbut, R., Grodzińska, L., & Ocetkiewicz, A. (1975) · Prostaglandins · doi:10.1016/0090-6980(75)90053-2 · Cited by 241
Rubinstein, M., Marazzi, A., & Polak de Fried, E. (1999) · Fertility and Sterility · doi:10.1016/s0015-0282(99)00088-6 · Cited by 241
Colville-Nash, P. R., Qureshi, S. S., Willis, D., & Willoughby, D. A. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.2.978 · Cited by 241
Resveratrol is a Peroxidase-mediated Inactivator of COX-1 but Not COX-2
Szewczuk, L. M., Forti, L., Stivala, L. A., & Penning, T. M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m314302200 · Cited by 240
Aspirin: A Historical and Contemporary Therapeutic Overview
Fuster, V., & Sweeny, J. M. (2011) · Circulation · doi:10.1161/circulationaha.110.963843 · Cited by 238
Claria, J. (2003) · Current Pharmaceutical Design · doi:10.2174/1381612033454054 · Cited by 238
“In 1971, Vane [5], Ferreira et al.”
EFFECT OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS ON THE COURSE OF OSTEOARTHRITIS
Rashad, S., Hemingway, A., Rainsford, K., Revell, P., Low, F., & Walker, F. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90651-x · Cited by 238
Inhibition of Nuclear Factor Kappa B (NF-B):: An Emerging Theme in Anti-Inflammatory Therapies
D'Acquisto, F. (2002) · Molecular Interventions · doi:10.1124/mi.2.1.22 · Cited by 237
Lack of tactile pain (allodynia) in lipocalin-type prostaglandin D synthase-deficient mice
Eguchi, N., Minami, T., Shirafuji, N., Kanaoka, Y., Tanaka, T., Nagata, A., Yoshida, N., Urade, Y., Ito, S., & Hayaishi, O. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.2.726 · Cited by 237
Counteraction of the vasodilator effects of enalapril by aspirin in severe heart failure
Hall, D., Zeitler, H., & Rudolph, W. (1992) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(92)90449-w · Cited by 237
Malik, K. U., & McGiff, J. C. (1975) · Circulation Research · doi:10.1161/01.res.36.5.599 · Cited by 237
Grieve, W. G., Johnson, G. K., Moore, R. N., Reinhardt, R. A., & DuBois, L. M. (1994) · American Journal of Orthodontics and Dentofacial Orthopedics · doi:10.1016/s0889-5406(94)70131-8 · Cited by 236
Rastogi, A., Tiwari, M. K., & Ghangrekar, M. M. (2021) · Journal of Environmental Management · doi:10.1016/j.jenvman.2021.113694 · Cited by 236
Paul-Clark, M. J., van Cao, T., Moradi-Bidhendi, N., Cooper, D., & Gilroy, D. W. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040566 · Cited by 236
An electronic pressure-meter nociception paw test for rats
Vivancos, G. G., Verri Jr., W. A., Cunha, T. M., Schivo, I. R. S., Parada, C. A., Cunha, F. Q., & Ferreira, S. H. (2004) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2004000300017 · Cited by 235
Mishra, D. K., Fridén, J., Schmitz, M. C., & Lieber, R. L. (1995) · The Journal of Bone & Joint Surgery · doi:10.2106/00004623-199510000-00005 · Cited by 235
Dependency of Renal Blood Flow on Prostaglandin Synthesis in the Dog
Lonigro, A. J., Itskovitz, H. D., Crowshaw, K., & McGiff, J. C. (1973) · Circulation Research · doi:10.1161/01.res.32.6.712 · Cited by 235
A Perspective: Engineering Periosteum for Structural Bone Graft Healing
Zhang, X., Awad, H. A., O’Keefe, R. J., Guldberg, R. E., & Schwarz, E. M. (2008) · Clinical Orthopaedics and Related Research · doi:10.1007/s11999-008-0312-6 · Cited by 234
Non-steroidal anti-inflammatory drugs in Parkinson's disease
Esposito, E., Di Matteo, V., Benigno, A., Pierucci, M., Crescimanno, G., & Di Giovanni, G. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.02.008 · Cited by 234
Nonsteroidal Anti-inflammatory Drug Use and Acute Myocardial Infarction
Solomon, D. H., Glynn, R. J., Levin, R., & Avorn, J. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.10.1099 · Cited by 234
Morgan, M. K. (1979) · Anaesthesia · doi:10.1111/j.1365-2044.1979.tb04862.x · Cited by 234
Strzelec, M., Detka, J., Mieszczak, P., Sobocińska, M. K., & Majka, M. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1127704 · Cited by 233
“The inhibition of cyclooxygenase enzymes leads to prostaglandin synthesis inhibition (69).”
Background
Metadata
- Authors
- VANE, J. R.
- Affiliations
- Royal College of Surgeons of England (GB)
- Corresponding author
- VANE, J. R.
- Venue
- Nature New Biology
- Published
- 1971-06
- Volume
- 231
- Issue
- 25
- Pages
- 232-235
- ISSN
- 0090-0028 (ISSN-L)
- 2058-1092
- OpenAlex
- W2008574207
- Cited by
- 8,605
- References
- 26
- Citations by year
- 2026: 51 · 2025: 72 · 2024: 86 · 2023: 106 · 2022: 117 · 2021: 121 · 2020: 118 · 2019: 114 · 2018: 123 · 2017: 150 · 2016: 144 · 2015: 154 · 2014: 154 · 2013: 162 · 2012: 190
- FWCI
- 183.22
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature New Biology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
- Physical Sciences › Chemistry › Organic Chemistry › Heterocyclic Compound Synthesis and Bioactivity
- Keywords
- aspirin, salicylates, prostaglandin synthesis inhibition, mechanism of action, guinea pig lung, anti-inflammatory agents
- MeSH terms
- Animals, Arachidonic Acids, Aspirin, Biological Assay, Chromatography, Thin Layer, Colon, Guinea Pigs, Indomethacin, Lung, Prostaglandins, Salicylates, Stomach, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.